Core Laboratories (CLB) Misses Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts CLB Hot Sheet
Price: $9.65 -1.23%
Financial Fact:
Income Tax Expense (Benefit): 2.08M
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Income Tax Expense (Benefit): 2.08M
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Core Laboratories (NYSE: CLB) reported Q2 EPS of $0.18, $0.02 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $118.7 million versus the consensus estimate of $119.38 million.
GUIDANCE:
Core Laboratories sees Q3 2021 EPS of $0.19-$0.21, versus the consensus of $0.23.
For earnings history and earnings-related data on Core Laboratories (CLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Applovin shares surge on strong Q3 results and guidance
- AMERCO (UHAL) Misses Q2 EPS by 13c
- Redwire Corporation (RDW) Tops Q3 EPS by 3c, Misses on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
